{
  "slug": "roche-genentech",
  "name": "roche-genentech",
  "description": "Roche-Genentech is a leading biotechnology company that discovers, develops, manufactures, and commercializes medicines for serious medical conditions. It operates as an independent research and development center of Roche, focusing on areas such as oncology, immunology, neuroscience, and infectious diseases.",
  "url": "https://optimly.ai/brand/roche-genentech",
  "websiteUrl": "https://roche-genentech.com/",
  "logoUrl": "https://logo.clearbit.com/roche-genentech.com",
  "baiScore": 55,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": "Incumbent",
  "archetype_status": "active",
  "category": "Pharmaceuticals",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-08-09T00:03:07.015Z",
  "verifiedVitals": {
    "website": "https://roche-genentech.com",
    "founded": "1976",
    "headquarters": "South San Francisco, California, USA",
    "pricing_model": "Complex, value-based pricing models common in the pharmaceutical industry, often involving negotiations with healthcare systems, insurers, and governments.",
    "core_products": "Biologic drugs and therapeutics for cancer (e.g., Avastin, Herceptin, Tecentriq), autoimmune diseases (e.g., Ocrevus, Rituxan), and other serious conditions.",
    "key_differentiator": "Pioneering role in biotechnology, strong and consistent investment in cutting-edge research and development, focus on personalized medicine, and the backing of the global pharmaceutical giant Roche.",
    "target_markets": "Patients with severe medical conditions (oncology, neurology, immunology, infectious diseases), healthcare providers, hospitals, and research institutions worldwide.",
    "employee_count": "13000+",
    "funding_stage": "Publicly traded (as part of Roche Holding AG)",
    "subcategory": "Biotechnology"
  },
  "intentTags": {
    "problemIntents": [
      "Traditional Drug Discovery & Development: Relying solely on conventional laboratory research, empirical testing, and manual data analysis for drug discovery and clinical trials, without the aid of adv",
      "Contract Research Organizations (CROs): Outsourcing clinical trials and some research activities to CROs that may not employ advanced AI/ML tools, instead using standard methodologies for data collect",
      "Maintain Status Quo without AI Adoption: Continuing with existing drug development and research processes without integrating new AI/ML technologies. This would lead to slower innovation, increased co"
    ],
    "solutionIntents": [
      "Genentech cancer drugs",
      "Roche Genentech research pipeline",
      "Who owns Genentech",
      "Genentech immunology treatments",
      "Genentech headquarters",
      "Generic Data Analytics Platforms: Utilizing general-purpose big data analytics and statistical software without specialized AI models tailored for biological data, drug discovery, or personalized medi"
    ],
    "evaluationIntents": []
  },
  "businessProfileClaims": [],
  "timestamp": 1786547748436
}